MX350201B - Composiciones oftalmicas con ceras alcoxiladas naturales. - Google Patents
Composiciones oftalmicas con ceras alcoxiladas naturales.Info
- Publication number
- MX350201B MX350201B MX2014009949A MX2014009949A MX350201B MX 350201 B MX350201 B MX 350201B MX 2014009949 A MX2014009949 A MX 2014009949A MX 2014009949 A MX2014009949 A MX 2014009949A MX 350201 B MX350201 B MX 350201B
- Authority
- MX
- Mexico
- Prior art keywords
- ophthalmic compositions
- alkoxylated
- natural waxes
- alkoxylated natural
- ophthalmic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/36—Caryophyllaceae (Pink family), e.g. babysbreath or soapwort
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L12/00—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor
- A61L12/08—Methods or apparatus for disinfecting or sterilising contact lenses; Accessories therefor using chemical substances
- A61L12/14—Organic compounds not covered by groups A61L12/10 or A61L12/12
- A61L12/141—Biguanides, e.g. chlorhexidine
- A61L12/142—Polymeric biguanides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/667—Neutral esters, e.g. sorbitan esters
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D1/00—Detergent compositions based essentially on surface-active compounds; Use of these compounds as a detergent
- C11D1/66—Non-ionic compounds
- C11D1/74—Carboxylates or sulfonates esters of polyoxyalkylene glycols
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/0005—Other compounding ingredients characterised by their effect
- C11D3/0078—Compositions for cleaning contact lenses, spectacles or lenses
-
- C—CHEMISTRY; METALLURGY
- C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
- C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
- C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
- C11D3/48—Medical, disinfecting agents, disinfecting, antibacterial, germicidal or antimicrobial compositions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Eyeglasses (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente invención se refiere a una composición oftálmica caracterizada porque comprende del 0,005% en peso al 2,0% en peso de ceras naturales alcoxiladas seleccionadas del grupo que consiste en lanolina alcoxilada y jojoba alcoxilada, y del 0, 002% en peso al 0,2% en peso de ácido hialurónico o del 0, 05% en peso al 0, 3% en peso de hidroxipropil guar.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261602764P | 2012-02-24 | 2012-02-24 | |
PCT/US2013/020998 WO2013126155A1 (en) | 2012-02-24 | 2013-01-10 | Ophthalmic compositions with alkoxylated natural waxes |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014009949A MX2014009949A (es) | 2014-11-10 |
MX350201B true MX350201B (es) | 2017-08-30 |
Family
ID=47757683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014009949A MX350201B (es) | 2012-02-24 | 2013-01-10 | Composiciones oftalmicas con ceras alcoxiladas naturales. |
Country Status (11)
Country | Link |
---|---|
US (1) | US9375401B2 (es) |
EP (1) | EP2816996B1 (es) |
JP (1) | JP2015509495A (es) |
KR (1) | KR101726029B1 (es) |
CN (1) | CN104136005A (es) |
AU (1) | AU2013222801B2 (es) |
CA (1) | CA2864833C (es) |
ES (1) | ES2609013T3 (es) |
MX (1) | MX350201B (es) |
PL (1) | PL2816996T3 (es) |
WO (1) | WO2013126155A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020123362A1 (en) | 2018-12-10 | 2020-06-18 | EternaTear, Inc. | Ophthalmic formulations providing durable ocular lubrication |
KR102365008B1 (ko) * | 2020-06-23 | 2022-02-23 | 주식회사태준제약 | 디쿠아포솔을 포함하는 점안 조성물 |
US11471475B1 (en) | 2022-03-08 | 2022-10-18 | Ralph P. Stone | Ophthalmic suspension vehicles and related methods for pharmaceutical ingredient delivery |
US11679078B1 (en) | 2022-03-08 | 2023-06-20 | EternaTear, Inc. | Ophthalmic formulations and related methods |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3374144A (en) * | 1965-10-07 | 1968-03-19 | Miles Lab | Ophthalmic composition |
US4409205A (en) | 1979-03-05 | 1983-10-11 | Cooper Laboratories, Inc. | Ophthalmic solution |
US4758595A (en) | 1984-12-11 | 1988-07-19 | Bausch & Lomb Incorporated | Disinfecting and preserving systems and methods of use |
US5209927A (en) | 1985-01-23 | 1993-05-11 | Alcon Laboratories, Inc. | Ophthalmic solution |
DE69115990T2 (de) | 1990-05-29 | 1996-05-30 | Ocular Res Of Bonton Inc | Zusammensetzung zur Behandlung von Dry Eye Erkrankungen |
JPH0477434A (ja) | 1990-07-17 | 1992-03-11 | Kanji Takada | 顆粒球コロニー刺激因子の眼粘膜適用製剤 |
JP2000109892A (ja) | 1998-10-02 | 2000-04-18 | Rohto Pharmaceut Co Ltd | 多糖含有コンタクトレンズ用液剤 |
JP2002308775A (ja) | 2001-04-06 | 2002-10-23 | Rohto Pharmaceut Co Ltd | 外用組成物 |
JP2003081840A (ja) * | 2001-07-04 | 2003-03-19 | Rohto Pharmaceut Co Ltd | 清涼化方法、清涼化剤および外用組成物 |
US6695123B2 (en) | 2001-12-21 | 2004-02-24 | Richwood Industries, Inc. | Conveyor belt cleaner blade |
TWI322828B (en) | 2002-12-23 | 2010-04-01 | Alcon Inc | Use of multifunctional surface active agents to clean contact lenses |
US20040137079A1 (en) * | 2003-01-08 | 2004-07-15 | Cook James N. | Contact lens and eye drop rewetter compositions and methods |
JP2004238346A (ja) * | 2003-02-07 | 2004-08-26 | Shiono Chemical Co Ltd | トラニラストの安定な水溶液製剤 |
US20050196370A1 (en) * | 2003-03-18 | 2005-09-08 | Zhi-Jian Yu | Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye |
WO2006079830A1 (en) | 2005-01-29 | 2006-08-03 | Croda International Plc | Alkoxylated lanolin derivatives and compositions therewith |
CN101185650B (zh) * | 2006-11-27 | 2010-07-28 | 中国医学科学院医药生物技术研究所 | 喷昔洛韦眼用温度敏感原位凝胶制剂及其制备方法 |
US8119112B2 (en) | 2008-01-31 | 2012-02-21 | Bausch & Lomb Incorporated | Ophthalmic compositions with an amphoteric surfactant and hyaluronic acid |
US8802653B2 (en) * | 2010-10-01 | 2014-08-12 | C.B. Fleet Company, Inc. | Deodorant compositions |
-
2013
- 2013-01-10 EP EP13707060.3A patent/EP2816996B1/en active Active
- 2013-01-10 AU AU2013222801A patent/AU2013222801B2/en active Active
- 2013-01-10 ES ES13707060.3T patent/ES2609013T3/es active Active
- 2013-01-10 MX MX2014009949A patent/MX350201B/es active IP Right Grant
- 2013-01-10 WO PCT/US2013/020998 patent/WO2013126155A1/en active Application Filing
- 2013-01-10 KR KR1020147026318A patent/KR101726029B1/ko active IP Right Grant
- 2013-01-10 CN CN201380010561.3A patent/CN104136005A/zh active Pending
- 2013-01-10 CA CA2864833A patent/CA2864833C/en active Active
- 2013-01-10 US US14/377,460 patent/US9375401B2/en active Active
- 2013-01-10 PL PL13707060T patent/PL2816996T3/pl unknown
- 2013-01-10 JP JP2014558739A patent/JP2015509495A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
MX2014009949A (es) | 2014-11-10 |
EP2816996A1 (en) | 2014-12-31 |
US20150297511A1 (en) | 2015-10-22 |
WO2013126155A1 (en) | 2013-08-29 |
AU2013222801B2 (en) | 2015-09-17 |
US9375401B2 (en) | 2016-06-28 |
JP2015509495A (ja) | 2015-03-30 |
AU2013222801A1 (en) | 2014-09-04 |
CA2864833C (en) | 2017-01-03 |
ES2609013T3 (es) | 2017-04-18 |
EP2816996B1 (en) | 2016-10-05 |
CN104136005A (zh) | 2014-11-05 |
KR20140124859A (ko) | 2014-10-27 |
CA2864833A1 (en) | 2013-08-29 |
PL2816996T3 (pl) | 2017-04-28 |
KR101726029B1 (ko) | 2017-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY169328A (en) | Compositions for the treatment of dry eye | |
MY171920A (en) | Prevention and treatment of ocular conditions | |
SG10201809290SA (en) | Compositions and Methods to Treating Hemoglobinopathies | |
MA39767A (fr) | Solution aqueuse ophtalmique et méthode de traitement du syndrome de l'oeil sec | |
WO2013061309A3 (en) | New a-prp medical device & tissue engineering composition, manufacturing machines and process | |
MX2013004061A (es) | Analogos de ciclosporina. | |
MX359327B (es) | Composiciones y sus usos para tratar y prevenir la enfermedad de huntington. | |
MX2012004551A (es) | Nuevas composiciones para prevenir y/o tratar trastornos de almacenamiento lisosomal. | |
EA201591743A1 (ru) | СТИМУЛЯТОРЫ sGC | |
NZ727304A (en) | Compositions and methods of use of phorbol esters for the treatment of stroke | |
SG10201808104RA (en) | Cenicriviroc for the treatment of fibrosis | |
MY180581A (en) | A crystalline form of cyclosporine a, methods of preparation, and methods for use thereof | |
PH12017500922A1 (en) | Stabilized omega-3 ophthalmic compositions | |
MX2016008226A (es) | Metodos para el cuidado oral prebiotico usando un sacarido. | |
MX2013004062A (es) | Analogos de ciclosporina. | |
PH12017500615A1 (en) | Ophthalmic composition comprising cyclosporine and trehalose | |
WO2012080497A3 (en) | Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases | |
WO2016094834A3 (en) | A method for treating a complement mediated disorder caused by an infectious agent in a patient | |
PH12017500637A1 (en) | Inhibitors of lysine gingipain | |
MX350201B (es) | Composiciones oftalmicas con ceras alcoxiladas naturales. | |
MX2017004760A (es) | Formulacion esterilizada por calor que comprende quitosan y proceso para preparacion de la misma. | |
TW201613628A (en) | Combination of valerian root extract and lavender oil for use in the treatment of sleep disorders | |
MX2019012375A (es) | Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1). | |
MX2013015419A (es) | Dha y epa en la reduccion de estres oxidante. | |
BR112013021035A2 (pt) | composições e métodos de reposição de tecido macio aperfeiçoados |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |